RNF4 and heart disorder: To investigate the role of RNF4 in heart disease, GFP‐labelled AAV9‐shRNA targeting RNF4 was delivered into the heart to specifically knockdown cardiac endogenous RNF4 via in vivo adeno‐associated virus infection, which is a well‐established experimental technique used in cardiovascular research.20, 21, 22